ALK and neoplasm: One invalid test result was obtained using the IdyllaTM GeneFusion Assay, for which the reference reported an ALK fusion; the sample tested was however smaller (0–20 mm2) with low tumor cell content (10–20%) and confirmed to be a less-quality sample as commented to be indicative for RNA degradation.